Skip to main content
Fig. 2 | Malaria Journal

Fig. 2

From: Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial

Fig. 2

Overall treatment frequency and pattern for the ivermectin MDA excluding non-eligible participants. Full points indicate MDA received. IVMD# denotes the number of ivermectin doses received, and the pattern such as a single dose or all nine MDA rounds. Certain patterns, such as received 1st and 9th MDA but none in between are excluded for convenience, therefore data for only 2347/2730 participants are show are shown

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us